Matinas BioPharma

Gilead nixes Matinas oral COVID-19 antiviral to focus on late-phase internal program
Fierce Biotech
Wed, 02/1/23 - 10:30 am
Gilead Sciences
Matinas BioPharma
COVID-19
antivirals